You are viewing: Rest Of Europe Carrier Screening Market analysis
Part of: Carrier Screening Market (Global)

The Rest Of Europe Carrier Screening Market was valued at $64.2 Million in 2023 and projected to reach to $136.8 Million by 2028, representing a compound annual growth rate of 16.3%. Rest Of Europe's carrier screening market is positioned for substantial growth through 2028, driven by increasing healthcare investments and rising consumer awareness of genetic health risks.

Rest Of Europe Carrier Screening Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Carrier Screening Market Trends and Insights

  • Rest Of Europe is experiencing accelerated adoption of carrier screening technologies driven by increasing awareness of genetic disorders, expanding healthcare infrastructure, and growing demand for preventive genetic testing.
  • By 2028, Rest Of Europe's market is forecast to reach $136.8 million, representing a compound annual growth rate of 16.3%, reflecting strong regional investment in reproductive health and personalized medicine initiatives. Rest Of Europe's carrier screening landscape is characterized by rising healthcare expenditures and supportive regulatory frameworks that facilitate market penetration.
  • The region's growth trajectory outpaces many mature markets, as Rest Of Europe continues to integrate advanced genetic testing into standard prenatal and preconception care protocols.
  • Rest Of Europe's expanding middle class and improved access to diagnostic services are key catalysts driving market expansion between 2023 and 2028..

Key Market Statistics

  • CAGR (2023-2028) 16.3% CAGR
  • Market Size, 2023 ~USD 64.2 Million
  • Forecast, 2028 ~USD 136.8 Million
  • Country Rest Of Europe

Rest Of Europe Carrier Screening Market Overview

Market Valuation Growth :

Rest Of Europe carrier screening market valued at $64.2 million in 2023, projected to reach $136.8 million by 2028, representing a robust 16.3% CAGR over the forecast period.

Accelerated Technology Adoption :

Rest Of Europe is experiencing rapid adoption of advanced carrier screening technologies driven by increased awareness of genetic disorders and growing demand for preventive genetic testing across the region.

Healthcare Infrastructure Expansion :

Expanding healthcare infrastructure across Rest Of Europe countries is facilitating improved access to carrier screening services, supporting market growth and regional penetration of genetic testing solutions.

Preventive Healthcare Focus :

Growing emphasis on preventive genetic testing in Rest Of Europe reflects shifting healthcare paradigms toward early detection and risk assessment, driving demand for comprehensive carrier screening programs.

Rest Of Europe Carrier Screening Market Dynamics

  • The region's expanding middle class and improving healthcare accessibility are creating favorable conditions for market expansion.
  • Healthcare providers across Rest Of Europe are increasingly integrating carrier screening into routine prenatal and preconception care protocols, supporting market penetration. The competitive landscape in Rest Of Europe is evolving with both established diagnostic companies and emerging biotech firms expanding their presence.
  • Regulatory harmonization efforts and growing reimbursement coverage for genetic testing are expected to accelerate adoption rates.
  • Strategic partnerships between regional healthcare systems and genetic testing providers will further strengthen market dynamics through 2028..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Rest Of Europe's carrier screening market is valued at $64.2 million in 2023 and is projected to more than double to $136.8 million by 2028.
      • Rest Of Europe is experiencing a 16.3% CAGR, driven by increased genetic awareness and integration of screening into standard reproductive care.
      • Rest Of Europe's market growth is supported by expanding healthcare infrastructure and rising healthcare expenditures across the region.
      • Rest Of Europe's improving access to diagnostic services and growing middle class are key factors accelerating market adoption through 2028.

      Carrier Screening Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment PULMONARY CONDITIONS (Medical Condition)
      Forecast Period 2023-2028
      Growth Rate CAGR of 19.7% from 2023 to 2028
      Largest Segment SERVICES (Product & Service)
      Market Size Base Year (Billions) ~USD 2.2 (2023)
      Revenue Forecast (Billions) ~USD 5.4 (2028)
      Segments Covered Product & Service, Type, Medical Condition, Technology, End User, Product & 2021-2028

      Rest Of Europe Carrier Screening Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product & Service

      • Products
      • Services

      By Type

      • Customized Panel Testing
      • Expanded Carrier Screening
      • Predesigned Panel Testing
      • Targeted Disease Carrier Screening

      By Medical Condition

      • Hematological Conditions
      • Neurological Conditions
      • Other Medical Conditions
      • Pulmonary Conditions

      By Technology

      • Dna Microarrays
      • Dna Sequencing
      • Other Technologies
      • Pcr

      By End User

      • Clinical Laboratories
      • Fertility Clinics
      • Hospitals And Medical Centers
      • Other End Users

      By Product & 2021-2028

      • Products
      • Services

      Target Audience

      • Diagnostic Companies : Genetic testing and diagnostic firms need Rest Of Europe market data to identify expansion opportunities, assess regional demand, and develop localized carrier screening product strategies.
      • Healthcare Providers : Hospitals and clinics across Rest Of Europe require market insights to justify investments in carrier screening infrastructure and understand regional adoption trends for genetic testing services.
      • Investment & Private Equity : Investors evaluating biotech and healthcare opportunities in Rest Of Europe need market sizing and growth forecasts to assess portfolio companies and identify acquisition targets in genetic screening.
      • Pharmaceutical & Biotech Firms : Companies developing genetic testing solutions need Rest Of Europe-specific market data to guide R&D investments, commercialization strategies, and regional partnership development.
      • Healthcare Policy Makers : Government health agencies and regulatory bodies in Rest Of Europe require market intelligence to inform reimbursement policies, healthcare planning, and genetic screening program development.

      Reasons to Buy this Report

      • Regional Market Sizing : Obtain precise market valuation data specific to Rest Of Europe ($64.2M in 2023), enabling accurate budget allocation and investment decisions for regional expansion strategies.
      • Growth Trajectory Insights : Access detailed CAGR analysis (16.3%) and 2028 forecast projections ($136.8M) to identify market timing opportunities and competitive positioning within Rest Of Europe's genetic screening sector.
      • Regional Adoption Drivers : Understand Rest Of Europe-specific factors driving carrier screening adoption, including healthcare infrastructure development, awareness trends, and preventive care initiatives unique to the region.
      • Competitive Landscape Assessment : Benchmark your organization against regional competitors with market intelligence tailored to Rest Of Europe's carrier screening ecosystem, including emerging players and established diagnostic providers.
      • Strategic Market Entry Planning : Develop informed market entry or expansion strategies for Rest Of Europe with comprehensive data on market dynamics, growth opportunities, and regional healthcare system requirements.

      Frequently asked questions

      What is the current size of the Rest Of Europe carrier screening market?

      Rest Of Europe's carrier screening market was valued at $64.2 million in 2023 and is expected to grow significantly through the forecast period.

      What is the projected market size for Rest Of Europe by 2028?

      Rest Of Europe's carrier screening market is forecast to reach $136.8 million by 2028, representing substantial growth from the 2023 baseline.

      What is the CAGR for Rest Of Europe's carrier screening market?

      Rest Of Europe's carrier screening market is projected to grow at a compound annual growth rate of 16.3% between 2023 and 2028.

      What factors are driving growth in Rest Of Europe's carrier screening market?

      Rest Of Europe's market growth is driven by increased genetic awareness, expanding healthcare infrastructure, rising healthcare expenditures, and integration of screening into standard reproductive care protocols.

      How does Rest Of Europe's carrier screening market compare to other regions?

      Rest Of Europe's 16.3% CAGR demonstrates strong regional momentum, with market expansion supported by improving diagnostic access and growing middle-class populations seeking preventive genetic testing.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the Carrier Screening Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

      Primary Research

      Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons, Gynecologist, genetic consultant) and supply sides (Carrier Screening product/service providers and distributors).

      The following is a breakdown of the primary respondents:

      Breakdown of Primary Participants:

      Carrier Screening Market  Size, and Share

      Note 1: Others include sales managers, marketing managers, and product managers.

      Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the Carrier Screening Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and markets have been identified through extensive secondary research
      • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Carrier Screening Market  Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Carrier Screening Market  Size, and Share

      Data Triangulation

      After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Carrier Screening Market industry.

      Market Definition

      Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive disease. Similarly, when it is done before or during pregnancy, it allows to find out the chances of having a child with a genetic disorder. Carrier screening involves testing a sample of blood, saliva, or tissue from the inside of the cheek.

      Market Stakeholders

      • Carrier screening product manufacturers, vendors, and distributors
      • Carrier screening service companies
      • Hospitals and private physician clinics
      • Reference laboratories
      • Donor banks
      • Health insurance payers
      • Research & consulting firms
      • Diagnostic Centers, and Medical Colleges
      • Research Institutes
      • Clinical Laboratories
      • Distributors of Carrier Screening Products and services

      Report Objectives

      • To define, describe, and forecast the global Carrier Screening Market based on Product & Service, Type, Medical Condition, Technology, End User, and Region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)  
      • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
      • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
      • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Carrier Screening Market.

      Available Customizations:

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

      • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
      • Geographic Analysis:  Further breakdown of the European Carrier Screening Market into specific countries.  

      Get the Full Carrier Screening Market Report

      Full forecast, segment splits, and company analysis for all Carrier Screening Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status